144 related articles for article (PubMed ID: 9294620)
1. Genetic variation of 3 beta-hydroxysteroid dehydrogenase type II in three racial/ethnic groups: implications for prostate cancer risk.
Devgan SA; Henderson BE; Yu MC; Shi CY; Pike MC; Ross RK; Reichardt JK
Prostate; 1997 Sep; 33(1):9-12. PubMed ID: 9294620
[TBL] [Abstract][Full Text] [Related]
2. SRD5A2 and HSD3B2 polymorphisms are associated with prostate cancer risk and aggressiveness.
Neslund-Dudas C; Bock CH; Monaghan K; Nock NL; Yang JJ; Rundle A; Tang D; Rybicki BA
Prostate; 2007 Nov; 67(15):1654-63. PubMed ID: 17823934
[TBL] [Abstract][Full Text] [Related]
3. Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk.
Reichardt JK; Makridakis N; Henderson BE; Yu MC; Pike MC; Ross RK
Cancer Res; 1995 Sep; 55(18):3973-5. PubMed ID: 7664265
[TBL] [Abstract][Full Text] [Related]
4. GEN GEN: the genomic genetic analysis of androgen-metabolic genes and prostate cancer as a paradigm for the dissection of complex phenotypes.
Reichardt JK
Front Biosci; 1999 Jul; 4():D596-600. PubMed ID: 10417059
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) gene can cause premature pubarche in girls.
Marui S; Castro M; Latronico AC; Elias LL; Arnhold IJ; Moreira AC; Mendonca BB
Clin Endocrinol (Oxf); 2000 Jan; 52(1):67-75. PubMed ID: 10651755
[TBL] [Abstract][Full Text] [Related]
6. Human 3beta-hydroxysteroid dehydrogenase types 1 and 2: Gene sequence variation and functional genomics.
Wang L; Salavaggione E; Pelleymounter L; Eckloff B; Wieben E; Weinshilboum R
J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):88-99. PubMed ID: 17689071
[TBL] [Abstract][Full Text] [Related]
7. A polymorphism of the 5 alpha-reductase gene and its association with prostate cancer: a case-control analysis.
Kantoff PW; Febbo PG; Giovannucci E; Krithivas K; Dahl DM; Chang G; Hennekens CH; Brown M; Stampfer MJ
Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):189-92. PubMed ID: 9138662
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2).
Lunn RM; Bell DA; Mohler JL; Taylor JA
Carcinogenesis; 1999 Sep; 20(9):1727-31. PubMed ID: 10469617
[TBL] [Abstract][Full Text] [Related]
9. Failure to find exon 7 polymorphism of the ADH7 gene in Chinese, Japanese, African-Americans, and Caucasians.
Carr LG; Zeng D; Li TK
Alcohol Clin Exp Res; 1996 May; 20(3):418-9. PubMed ID: 8727230
[TBL] [Abstract][Full Text] [Related]
10. Prostatic steroid 5 alpha-reductase, an androgen metabolic gene.
Reichardt JK
Mayo Clin Proc; 2000 Jan; 75 Suppl():S36-9. PubMed ID: 10959214
[TBL] [Abstract][Full Text] [Related]
11. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants.
Tanus-Santos JE; Desai M; Flockhart DA
Pharmacogenetics; 2001 Nov; 11(8):719-25. PubMed ID: 11692081
[TBL] [Abstract][Full Text] [Related]
12. Racial variation in insulin-like growth factor-1 and binding protein-3 concentrations in middle-aged men.
Platz EA; Pollak MN; Rimm EB; Majeed N; Tao Y; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1107-10. PubMed ID: 10613344
[TBL] [Abstract][Full Text] [Related]
13. Human CYP1B1 Leu432Val gene polymorphism: ethnic distribution in African-Americans, Caucasians and Chinese; oestradiol hydroxylase activity; and distribution in prostate cancer cases and controls.
Tang YM; Green BL; Chen GF; Thompson PA; Lang NP; Shinde A; Lin DX; Tan W; Lyn-Cook BD; Hammons GJ; Kadlubar FF
Pharmacogenetics; 2000 Dec; 10(9):761-6. PubMed ID: 11221602
[TBL] [Abstract][Full Text] [Related]
14. Common variants in the TCF7L2 gene and predisposition to type 2 diabetes in UK European Whites, Indian Asians and Afro-Caribbean men and women.
Humphries SE; Gable D; Cooper JA; Ireland H; Stephens JW; Hurel SJ; Li KW; Palmen J; Miller MA; Cappuccio FP; Elkeles R; Godsland I; Miller GJ; Talmud PJ
J Mol Med (Berl); 2006 Dec; 84(12):1005-14. PubMed ID: 17665514
[TBL] [Abstract][Full Text] [Related]
15. Dinucleotide repeat polymorphisms in the HSD3B2 gene.
Verreault H; Dufort I; Simard J; Labrie F; Luu-The V
Hum Mol Genet; 1994 Feb; 3(2):384. PubMed ID: 8004119
[No Abstract] [Full Text] [Related]
16. Characterization of an allelic variant in the nifedipine-specific element of CYP3A4: ethnic distribution and implications for prostate cancer risk. Mutations in brief no. 191. Online.
Walker AH; Jaffe JM; Gunasegaram S; Cummings SA; Huang CS; Chern HD; Olopade OI; Weber BL; Rebbeck TR
Hum Mutat; 1998; 12(4):289. PubMed ID: 10660343
[TBL] [Abstract][Full Text] [Related]
17. Cross-ethnic group comparisons of HLA class II alleles and insulin dependent diabetes mellitus.
Serjeantson SW; Easteal S
Baillieres Clin Endocrinol Metab; 1991 Jun; 5(2):299-320. PubMed ID: 1892468
[TBL] [Abstract][Full Text] [Related]
18. A minisatellite and a microsatellite polymorphism within 1.5 kb at the human muscle glycogen phosphorylase (PYGM) locus can be amplified by PCR and have combined informativeness of PIC 0.95.
Iwasaki H; Stewart PW; Dilley WG; Holt MS; Steinbrueck TD; Wells SA; Donis-Keller H
Genomics; 1992 May; 13(1):7-15. PubMed ID: 1349582
[TBL] [Abstract][Full Text] [Related]
19. Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects.
Carlini EJ; Raftogianis RB; Wood TC; Jin F; Zheng W; Rebbeck TR; Weinshilboum RM
Pharmacogenetics; 2001 Feb; 11(1):57-68. PubMed ID: 11207031
[TBL] [Abstract][Full Text] [Related]
20. Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans.
Haiman CA; Chen GK; Blot WJ; Strom SS; Berndt SI; Kittles RA; Rybicki BA; Isaacs WB; Ingles SA; Stanford JL; Diver WR; Witte JS; Chanock SJ; Kolb S; Signorello LB; Yamamura Y; Neslund-Dudas C; Thun MJ; Murphy A; Casey G; Sheng X; Wan P; Pooler LC; Monroe KR; Waters KM; Le Marchand L; Kolonel LN; Stram DO; Henderson BE
PLoS Genet; 2011 May; 7(5):e1001387. PubMed ID: 21637779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
